Pharma Solutions Flexible Robotic Technologies for Small Batch Aseptic Filling

Source: Press release Ahlam Rais 1 min Reading Time

Related Vendors

Steriline will be exhibiting its Robotic Nest Filling Machine at the upcoming Interphex 2023 trade fair in New York, USA. The firm’s technologies cater to the cell and gene therapy market.

Steriline will present a new Robotic Nest Filling Machine at Interphex 2023.  (Source:  Steriline)
Steriline will present a new Robotic Nest Filling Machine at Interphex 2023.
(Source: Steriline)

Steriline will present a new Robotic Nest Filling Machine at Interphex 2023 (Booth 2537), which is scheduled to be held from April 25 – 27 in New York, USA. The company’s robotic systems provide a high level of efficiency, safety and flexibility for the production of toxic and non-toxic drugs, reducing the risk of human error and improving overall quality, states the firm. Its technologies are specifically designed to meet the needs of key pharmaceutical sectors, such as the cell and gene therapy market, where quick turnaround of high-value product is critical.

Steriline's fully isolator-based robotic systems have a small footprint and are equipped with advanced technologies, including fully disposable fill paths, 100 % in-process check-weighing combined with a ‘zero-loss philosophy’.

Its solutions are designed according to the needs expressed by customers and are compatible with various primary containers such as vials, ampoules, cartridges, syringes and bags. The systems can handle products in both liquid and powder form and can be equipped with Laminar Air Flow (LAF), Open and Closed Restricted Access Barriers and Isolator Barrier Systems (ISOs) to ensure air monitoring and compliance with FDA regulations and current Good Manufacturing Practices (cGMPs), mentions the company.

(ID:49306557)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent